Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 1171 AL 1185

Does resveratrol improve cognition in humans? A scientometric study to an in-depth review

Tu W, Song M, Fan X.

CNS Neurosci Ther. 2023 Sep;29(9):2413-2429. doi: 10.1111/cns.14276. Epub 2023 May 29.

The Effects of Medium Chain Triglyceride for Alzheimer's Disease Related Cognitive Impairment: A Systematic Review and Meta-Analysis

Sun L, Ye KX, Wong HLK, Wang L, Lim SL, Chao YX, Zhang C, Yap KZ, Feng L.

J Alzheimers Dis. 2023;94(2):441-456. doi: 10.3233/JAD-230406.

Best Medicine for Dementia: The Life-Long Defense of the Brain

Andersson MJ, Stone J.

J Alzheimers Dis. 2023;94(1):51-66. doi: 10.3233/JAD-230429.

Structural and molecular imaging in dementia: the heterogeneity of Alzheimer's disease

Barkhof F.

Eur Radiol. 2023 Nov;33(11):8055-8056. doi: 10.1007/s00330-023-09751-5. Epub 2023 May 31.

[The controversy over early diagnosis of Alzheimer's disease: A literature review of the advantages and disadvantages]

Gräßel E, Lauer N.

Z Evid Fortbild Qual Gesundhwes. 2023 Jun;179:95-105. doi: 10.1016/j.zefq.2023.04.004. Epub 2023 May 30.

Imaging, Genetic, and Pathological Features of Vascular Dementia

Yang X, Chen C, Wang A, Li C, Cheng G.

Eur Neurol. 2023;86(4):277-284. doi: 10.1159/000531088. Epub 2023 Jun 3.

The Utility of Visual and Spatial Perception Tests in Alzheimer's Disease: A Systematic Review

Scott JP, Murphy DF, Noad RF.

Dement Geriatr Cogn Disord. 2023;52(4):195-204. doi: 10.1159/000530911. Epub 2023 Jun 2.

Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease: Research outline and call for collaboration

Lathe R, Schultek NM, Balin BJ, Ehrlich GD, Auber LA, Perry G, Breitschwerdt EB, Corry DB, Doty RL, Rissman RA, Nara PL, Itzhaki R, Eimer WA, Tanzi RE; Intracell Research Group Consortium Collaborators.

Alzheimers Dement. 2023 Nov;19(11):5209-5231. doi: 10.1002/alz.13076. Epub 2023 Jun 7.

Memory biases in Alzheimer's disease and mild cognitive impairment. A systematic review and metanalysis

De Vita D, Sagliano L, Trojano L.

Neurosci Biobehav Rev. 2023 Sep;152:105277. doi: 10.1016/j.neubiorev.2023.105277. Epub 2023 Jun 5.

Clustering of morbidities and risk of dementia

Hu Y.

J Epidemiol Community Health. 2023 Nov;77(11):685-686. doi: 10.1136/jech-2023-220779. Epub 2023 Jun 7.

Alcohol as a Modifiable Risk Factor for Alzheimer's Disease-Evidence from Experimental Studies

Chandrashekar DV, Steinberg RA, Han D, Sumbria RK.

Int J Mol Sci. 2023 May 30;24(11):9492. doi: 10.3390/ijms24119492.

Awareness of diagnosis predicts changes in quality of life in individuals with mild cognitive impairment and mild stage dementia

Stites SD, Rubright JD, Harkins K, Karlawish J.

Int J Geriatr Psychiatry. 2023 Jun;38(6):e5939. doi: 10.1002/gps.5939.

Longitudinal amyloid and tau PET imaging in Alzheimer's disease: A systematic review of methodologies and factors affecting quantification

Bollack A, Pemberton HG, Collij LE, Markiewicz P, Cash DM, Farrar G, Barkhof F; on behalf on the AMYPAD consortium.

Alzheimers Dement. 2023 Nov;19(11):5232-5252. doi: 10.1002/alz.13158. Epub 2023 Jun 12.

Promising neurostimulation routes for targeting the hippocampus to improve episodic memory: A review

Arulchelvan E, Vanneste S.

Brain Res. 2023 Sep 15;1815:148457. doi: 10.1016/j.brainres.2023.148457. Epub 2023 Jun 12.

Advancing screening for cognitive impairment: the memtrax continuous recognition test

Ashford JW, Clifford JO, Bergeron MF.

Aging (Albany NY). 2023 Jun 14;15(12):5230-5231. doi: 10.18632/aging.204828. Epub 2023 Jun 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias